Atlas Trials

BAX 826 Dose-Escalation Safety Study

Clinical trial NCT02716194 · COMPLETED

Trial details

NCT number
NCT02716194
Sponsor
Baxalta now part of Shire
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hemophilia A
Start date
2016-03-03
Primary completion
2017-01-17
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.